[{"address1": "Paasheuvelweg 25", "city": "Amsterdam", "zip": "1105 BP", "country": "Netherlands", "phone": "31 20 240 6000", "website": "https://www.uniqure.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.", "fullTimeEmployees": 209, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christian  Klemt", "age": 51, "title": "CFO, Principal Financial Officer & GM of Amsterdam Site", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 679793, "exercisedValue": 0, "unexercisedValue": 282015}, {"maxAge": 1, "name": "Dr. Jeannette  Potts J.D., Ph.D.", "age": 62, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 738547, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Walid  Abi-Saab M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 946132, "exercisedValue": 0, "unexercisedValue": 268795}, {"maxAge": 1, "name": "Prof. Hugo  Katus", "title": "Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Amin  Abujoub Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard  Porter Ph.D.", "age": 56, "title": "Chief Business & Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 732169, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tamara  Tugal Ph.D., MBA", "title": "Business Development Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Boyer", "title": "Chief People & Culture Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Eileen  Sawyer", "title": "Vice President of Global Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 6, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.06, "open": 10.21, "dayLow": 10.13, "dayHigh": 12.5, "regularMarketPreviousClose": 10.06, "regularMarketOpen": 10.21, "regularMarketDayLow": 10.13, "regularMarketDayHigh": 12.5, "payoutRatio": 0.0, "beta": 0.098, "forwardPE": -3.9575162, "volume": 3059427, "regularMarketVolume": 3059427, "averageVolume": 1608440, "averageVolume10days": 2085830, "averageDailyVolume10Day": 2085830, "bid": 12.05, "ask": 12.25, "bidSize": 1, "askSize": 1, "marketCap": 662768192, "fiftyTwoWeekLow": 3.73, "fiftyTwoWeekHigh": 19.18, "priceToSalesTrailing12Months": 24.439257, "fiftyDayAverage": 12.2893, "twoHundredDayAverage": 10.0917, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 677483392, "profitMargins": 0.0, "floatShares": 44484182, "sharesOutstanding": 54729000, "sharesShort": 5259762, "sharesShortPriorMonth": 3050960, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.096099995, "heldPercentInsiders": 0.084910005, "heldPercentInstitutions": 0.77345, "shortRatio": 3.7, "shortPercentOfFloat": 0.097399995, "impliedSharesOutstanding": 75752896, "bookValue": -0.138, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -239556000, "trailingEps": -4.92, "forwardEps": -3.06, "enterpriseToRevenue": 24.982, "enterpriseToEbitda": -3.999, "52WeekChange": 0.98422086, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 12.11, "targetHighPrice": 68.41213, "targetLowPrice": 12.890511, "targetMeanPrice": 35.15982, "targetMedianPrice": 29.653004, "recommendationMean": 1.46154, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 367520992, "totalCashPerShare": 6.796, "ebitda": -169430000, "totalDebt": 500991008, "quickRatio": 9.323, "currentRatio": 9.744, "totalRevenue": 27119000, "revenuePerShare": 0.557, "returnOnAssets": -0.16394, "returnOnEquity": -2.38461, "grossProfits": -132840000, "freeCashflow": -139787504, "operatingCashflow": -182728000, "revenueGrowth": -0.219, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -7.9626503, "financialCurrency": "USD", "symbol": "QURE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "uniQure N.V.", "longName": "uniQure N.V.", "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1746724524, "exchange": "NMS", "messageBoardId": "finmb_171029664", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1391610600000, "regularMarketChangePercent": 20.377726, "regularMarketPrice": 12.11, "regularMarketChange": 2.0499992, "regularMarketDayRange": "10.13 - 12.5", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1608440, "fiftyTwoWeekLowChange": 8.379999, "fiftyTwoWeekLowChangePercent": 2.2466486, "fiftyTwoWeekRange": "3.73 - 19.18", "fiftyTwoWeekHighChange": -7.0700006, "fiftyTwoWeekHighChangePercent": -0.36861315, "fiftyTwoWeekChangePercent": 98.42209, "earningsTimestamp": 1746793800, "earningsTimestampStart": 1746793800, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1746793800, "earningsCallTimestampEnd": 1746793800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -4.92, "epsForward": -3.06, "epsCurrentYear": -3.5939, "priceEpsCurrentYear": -3.3695984, "fiftyDayAverageChange": -0.17930031, "fiftyDayAverageChangePercent": -0.014589953, "twoHundredDayAverageChange": 2.0183, "twoHundredDayAverageChangePercent": 0.19999605, "priceToBook": -87.753624, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "uniQure", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]